Sense prevails on MRI rules

Scientists in Europe have been expressing linkurl:relief;http://www.guardian.co.uk/science/2007/oct/22/medicalresearch.health this week at the news that the European Union is dropping rules on the levels of radiation medical staff can be exposed to. The EU physical agents directive had triggered linkurl:consternation;http://www.the-scientist.com/article/display/22775/ a couple of years ago, with researchersworried it would be impossible to do certain kinds of studies and keep within the prescri

Written byStephen Pincock
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Scientists in Europe have been expressing linkurl:relief;http://www.guardian.co.uk/science/2007/oct/22/medicalresearch.health this week at the news that the European Union is dropping rules on the levels of radiation medical staff can be exposed to. The EU physical agents directive had triggered linkurl:consternation;http://www.the-scientist.com/article/display/22775/ a couple of years ago, with researchersworried it would be impossible to do certain kinds of studies and keep within the prescribed limits. The linkurl:rules;http://www.hpa.org.uk/radiation/understand/information_sheets/mri_ec_directive_2004_40_ec.htm were due to come into force by next year. But now, after some serious lobbying coordinated by the group Sense about Science, the EU has decided to delay the introduction of the laws for 4 years while they are revised.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies